News of the index components BEL-20

Index

BEL20

BE0389555039

Market Closed - Euronext Bruxelles 12:05:02 2024-05-20 pm EDT			5-day change	1st Jan Change
4,007 ^PTS	+0.05%		-0.16%	+8.07%

May. 10	Indexes already back on top
Mar. 07	Aperam: forthcoming delisting from BEL20	CF

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Solvay releases 2023 annual integrated report SOLB	Apr. 17	GL
AB INBEV : Bernstein maintains a Buy rating ABI	Apr. 17	ZD
UCB : FINTEPLA▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) UCB	Apr. 17	PU
Argenx : argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	PU
Syensqo releases inaugural 2023 annual integrated report SYENS	Apr. 16	GL
KBC Group: Update regarding the KBC Group share buyback programme KBC	Apr. 16	GL
Argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	GL
Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy ARGX	Apr. 16	CI
Groupe Bruxelles Lambert : GBL - Transactions sur actions propres 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transacties op GBL-aandelen 15-04-2024 GBLB	Apr. 15	PU
Solvay publishes 2023 quarterly information following restatement and new segmentation reporting SOLB	Apr. 15	GL
Solvay publishes 2023 quarterly information following restatement and new segmentation reporting SOLB	Apr. 15	AQ
UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting UCB	Apr. 15	AQ
Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall. SOLB	Apr. 15	CF
Ageas: BNP Paribas buys out Fosun's stake AGS	Apr. 15	CF
Ageas acknowledges BNP Paribas as shareholder AGS	Apr. 14	AQ
Ageas acknowledges BNP Paribas as shareholder AGS	Apr. 14	GL
UCB : Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY▼ (romosozumab) can help to close the treatment gap in osteoporosi UCB	Apr. 12	PU
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV AGS	Apr. 12	GL
Sofina : Liquidity agreement – 12/04/2024 SOF	Apr. 12	PU
Ageas publishes its 2023 reports AGS	Apr. 12	GL
Melexis N : 2023 - Melexis Annual Report MELE	Apr. 12	PU
Melexis N : 2023 - Melexis Statutory Report MELE	Apr. 12	PU
UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting UCB	Apr. 12	PU
Berenberg Reiterates UCB's Purchase Rating, Raises PT UCB	Apr. 11	MT
UCB : Berenberg, Buy, raises its price target UCB	Apr. 11	CF
D'Ieteren : Repurchase and disposal of own shares DIE	Apr. 10	PU
AB INBEV : Gets a Buy rating from Barclays ABI	Apr. 10	ZD
AB INBEV : Jefferies gives a Buy rating ABI	Apr. 09	ZD
AB INBEV : UBS sticks Neutral ABI	Apr. 09	ZD
D'Ieteren : PHE Day - 25 June 2024 DIE	Apr. 09	PU
D'Ieteren : PHE Day - 25 June 2024 (ENG) DIE	Apr. 09	PU
KBC Group: Update regarding the KBC Group share buyback programme KBC	Apr. 09	GL
Keybridge Capital Defeating Conditions Not Triggered in Yowie Takeover Offer KBC	Apr. 09	MT
Groupe Bruxelles Lambert : GBL - Transactions sur actions propres 08-04-2024 GBLB	Apr. 08	PU
Groupe Bruxelles Lambert : GBL - Transacties op GBL-aandelen 08-04-2024 GBLB	Apr. 08	PU
Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 08-04-2024 GBLB	Apr. 08	PU
AB INBEV : RBC reiterates its Buy rating ABI	Apr. 08	ZD
Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024 GLPG	Apr. 08	CI